BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses

European Journal of Immunology

Volumn 34, Issue 10, 2004, Pages 2750-2759

  Ye, Qunrui ^a   Wang, Liqing ^a   Wells, Andrew D ^a   Tao, Ran ^a   Han, Rongxiang ^a   Davidson, Anne ^b   Scott, Martin L ^c   Hancock, Wayne W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Bogen Inc   (United States)

Author keywords

Allograft; B cells; BAFF; Costimulation; T cells

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; CD4 ANTIGEN; CYCLOSPORIN A; MEMBRANE RECEPTOR; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7244223338     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425198     Document Type: Article

References (50)

1. Locksley, R. M., Killeen, N. and Lenardo, M. J., The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001. 104: 487-501.
2. Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L. and Tschopp, J., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999. 189: 1747-1756.
3. Shu, H. B., Hu, W. H. and Johnson, H., TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 1999. 65: 680-683.
4. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L. and Aggarwal, B. B., Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 1999. 274: 15978-15981.
5. Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D. et al., BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999. 285: 260-263.
6. Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C., Schneider, P., Sizing, I. D., Mullen, C. et al., BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001. 293: 2108-2111.
7. Yan, M., Brady, J. R., Chan, B., Lee, W. P., Hsu, B., Harless, S., Cancro, M., Grewal, I. S. and Dixit, V. M., Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 2001. 11: 1547-1552.
8. Laabi, Y. and Strasser, A., Immunology. Lymphocyte survival-ignorance is BLys. Science 2000. 289: 883-884.
9. Mackay, F. and Mackay, C. R., The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002. 23: 113-115.
10. Rolink, A. G. and Melchers, F., BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 2002. 14: 266-275.
11. Laabi, Y., Egle, A. and Strasser, A., TNF cytokine family: more BAFF-ling complexities. Curr. Biol. 2001. 11: R1013-1016.
12. Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L. and Mackay, F., BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 2000. 192: 1453-1466.
13. Thompson, J. S., Schneider, P., Kalled, S. L., Wang, L., Lefevre, E. A., Cachero, T. G., MacKay, F., Bixler, S. A., Zafari, M., Liu, Z. Y. et al., BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 2000. 192: 129-135.
14. Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C. et al., TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000. 404: 995-999.
15. Hahne, M., Kataoka, T., Schroter, M., Hofmann, K., Irmler, M., Bodmer, J. L., Schneider, P., Bornand, T., Holler, N., French, L. E. et al., APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 1998. 188: 1185-1190.
16. Madry, C., Laabi, Y., Callebaut, I., Roussel, J., Hatzoglou, A., Le Coniat, M., Mornon, J. P., Berger, R. and Tsapis, A., The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int. Immunol. 1998. 10: 1693-1702.
17. von Bulow, G. U. and Bram, R. J., NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 1997. 278: 138-141.
18. Huard, B., Schneider, P., Mauri, D., Tschopp, J. and French, L. E., T cell costimulation by the TNF ligand BAFF. J. Immunol. 2001. 167: 6225-6231.
19. Sarwal, M., Chua, M. S., Kambham, N., Hsieh, S. C., Satterwhite, T., Masek, M. and Salvatierra, O., Jr., Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 2003. 349: 125-138.
20. Michaels, P. J., Fishbein, M. C. and Colvin, R. B., Humoral rejection of human organ transplants. Springer Semin. Immunopathol. 2003. 25: 119-140.
21. Racusen, L. C., Immunopathology of organ transplantation. Springer Semin. Immunopathol. 2003. 25: 141-165.
22. Hancock, W. W., Buelow, R., Sayegh, M. H. and Turka, L. A., Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 1998. 4: 1392-1396.
23. Hatzoglou, A., Deshayes, F., Madry, C., Lapree, G., Castanas, E. and Tsapis, A., Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue. BMC Mol. Biol. 2002. 3: 4.
24. Schreiber, S. L. and Crabtree, G. R., The mechanism of action of cyclosporin A and FK506. Immunol. Today 1992. 13: 136-142.
25. Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N. and Luster, A. D., Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 2001. 193: 975-980.
26. Brandle, D., Joergensen, J., Zenke, G., Burki, K. and Hof, R. P., Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation 1998. 65: 1489-1493.
27. Suchin, E. J., Langmuir, P. B., Palmer, E., Sayegh, M. H., Wells, A. D. and Turka, L. A., Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 2001. 166: 973-981.
28. Lavie, F., Miceli-Richard, C., Quillard, J., Roux, S., Leclerc, P. and Mariette, X., Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J. Pathol. 2004. 202: 496-502.
29. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999. 190: 1697-1710.
30. Khare, S. D., Sarosi, I., Xia, X. Z., McCabe, S., Miner, K., Solovyev, I., Hawkins, N., Kelley, M., Chang, D., Van, G. et al., Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 2000. 97: 3370-3375.
31. Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J. et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 2002. 109: 59-68.
32. Xu, S. and Lam, K. P., B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell Biol. 2001. 21: 4067-4074.
33. Wang, H., Marsters, S. A., Baker, T., Chan, B., Lee, W. P., Fu, L., Tumas, D., Yan, M., Dixit, V. M., Ashkenazi, A. and Grewal, I. S., TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2001. 2: 632-637.
34. Stein, J. V., Lopez-Fraga, M., Elustondo, F. A., Carvalho-Pinto, C. E., Rodriguez, D., Gomez-Caro, R., De Jong, J., Martinez, A. C., Medema, J. P. and Hahne, M., APRIL modulates B and T cell immunity. J. Clin. Invest 2002. 109: 1587-1598.
35. Yu, G., Boone, T., Delaney, J., Hawkins, N., Kelley, M., Ramakrishnan, M., McCabe, S., Qiu, W., Kornuc, M., Xia, X. Z. et al., April and tall-i and receptors bcma and taci:system for regulating humoral immunity. Nat. Immunol. 2000. 1: 252-256.
36. Siegel, R. M. and Lenardo, M. J., To B or not to B: TNF family signaling in lymphocytes. Nat. Immunol. 2001. 2: 577-578.
37. von Bulow, G. U., vanDeursen, J. M. and Bram, R. J., Regulation of the T-independent humoral response by TACI. Immunity 2001. 14: 573-582.
38. Yan, M., Wang, H., Chan, B., Roose-Girma, M., Erickson, S., Baker, T., Tumas, D., Grewal, I. S. and Dixit, V. M., Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2001. 2: 638-643.
39. Miller, D. J. and Hayes, C. E., Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur J. Immunol. 1991. 21: 1123-1130.
40. Avery, D. T., Kalled, S. L., Ellyard, J. I., Ambrose, C., Bixler, S. A., Thien, M., Brink, R., Mackay, F., Hodgkin, P. D. and Tangye, S. G., BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 2003. 112: 286-297.
41. Aranda, J. M., Jr., Scornik, J. C., Normann, S. J., Lottenberg, R., Schofield, R. S., Pauly, D. F., Miles, M., Hill, J. A., Sleasman, J. W. and Skoda-Smith, S., Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002. 73: 907-910.
42. Zouali, M., B cell diversity and longevity in systemic autoimmunity. Mol. Immunol. 2002. 38: 895-901.
43. Mihara, M., Tan, I., Chuzhin, Y., Reddy, B., Budhai, L., Holzer, A., Gu, Y. and Davidson, A., CTLA4lg inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J. Clin. Invest. 2000. 106: 91-101.
44. Hancock, W. W., Sayegh, M. H., Zheng, X. G., Peach, R., Linsley, P. S. and Turka, L. A., Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 1996. 93: 13967-13972.
45. Ye, Q., Fraser, C. C., Gao, W., Wang, L., Busfield, S. J., Wang, C., Qiu, Y., Coyle, A. J., Gutierrez-Ramos, J. C. and Hancock, W. W., Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 2002. 195: 795-800.
46. + activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am. J. Transplant. 2003. 3: 1116-1120.
47. Ozkaynak, E., Gao, W., Shemmeri, N., Wang, C., Gutierrez-Ramos, J. C., Amaral, J., Qin, S., Rottman, J. B., Coyle, A. J. and Hancock, W. W., Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2001. 2: 591-596.
48. + T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J. Immunol. 1987. 138: 164-170.
49. Ozkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O'Keefe, T., Duong, T., Smith, T., Gutierrez-Ramos, J. C., Rottman, J. B. et al., Programmed death-1 targeting can promote allograft survival. J. Immunol. 2002. 169: 6546-6553.
50. Lee, I., Wang, L., Wells, A. D., Ye, Q., Han, R., Dorf, M. E., Kuziel, W. A., Rollins, B. J., Chen, L. and Hancock, W. W., Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 2003. 171: 6929-6935.